Accolade Inc Ordinary Shares ACCD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACCD is a good fit for your portfolio.
News
-
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
-
Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results
-
Accolade Wins 2024 Artificial Intelligence Excellence Award
-
Accolade Promotes Kelsi McDonald Harris to Chief People Officer
-
Accolade To Present at Upcoming Investor Conferences
-
Accolade Welcomes Brightline to Trusted Partner Ecosystem
Trading Information
- Previous Close Price
- $7.36
- Day Range
- $7.19–7.54
- 52-Week Range
- $6.33–15.21
- Bid/Ask
- $7.30 / $7.36
- Market Cap
- $576.71 Mil
- Volume/Avg
- 418,668 / 656,490
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.33
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 2,400
- Website
- https://www.accolade.com
Comparables
Valuation
|
Metric
|
ACCD
|
SPOK
|
DH
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 19.89 | 4.92 |
Price/Book Value | 1.29 | 1.91 | 0.75 |
Price/Sales | 1.33 | 2.19 | 2.45 |
Price/Cash Flow | 145.31 | 9.64 | 8.49 |
Price/Earnings
ACCD
SPOK
DH
Financial Strength
|
Metric
|
ACCD
|
SPOK
|
DH
|
|---|---|---|---|
Quick Ratio | 2.45 | 1.13 | 2.13 |
Current Ratio | 2.64 | 1.33 | 2.30 |
Interest Coverage | — | — | −19.76 |
Quick Ratio
ACCD
SPOK
DH
Profitability
|
Metric
|
ACCD
|
SPOK
|
DH
|
|---|---|---|---|
Return on Assets (Normalized) | −7.01% | 9.32% | 2.62% |
Return on Equity (Normalized) | −13.13% | 12.84% | 5.53% |
Return on Invested Capital (Normalized) | −8.66% | 11.47% | 3.26% |
Return on Assets
ACCD
SPOK
DH
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Ljpkcq | $36.8 Bil | |
VEEV
| Veeva Systems Inc Class A | Mvhnxhby | Mpj | $32.9 Bil | |
SOLV
| Solventum Corp | — | Smyxb | $11.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Grglt | $7.8 Bil | |
MTHRF
| M3 Inc | — | Pxtcfr | $7.3 Bil | |
MTHRY
| M3 Inc ADR | — | Lxtdg | $7.3 Bil | |
HQY
| HealthEquity Inc | — | Chknytk | $6.6 Bil | |
RCM
| R1 RCM Inc | — | Tpvg | $5.1 Bil | |
DOCS
| Doximity Inc Class A | — | Xnbkq | $4.4 Bil | |
TXG
| 10x Genomics Inc Ordinary Shares - Class A | — | Xklb | $3.2 Bil |